Teewinot Life Sciences Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Teewinot Life Sciences General Information

Description

Developer of patented biosynthetic manufacturing biotechnology methods designed to offer naturally-occurring cannabinoids and cannabinoid prodrugs. The company's methods help to improve human therapies and support to advance medical research and product development, enabling healthcare providers to address the therapeutics and wellness needs of the patients.

Contact Information

Website
www.tlscorp.com
Formerly Known As
CBC Biotechnologies
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • 13033 West Linebaugh Avenue
  • Tampa, FL 33626
  • United States
+1 (813) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Teewinot Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Admin/Reorg 27-Aug-2020 Completed Bankruptcy: Admin/Reorg
5. Later Stage VC 01-Aug-2020 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 28-Oct-2019 0000 Cancelled Generating Revenue
3. Early Stage VC 01-May-2017 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Mar-2017 $12.3M $19.3M 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 28-Feb-2016 $7M $7M 0000 Completed Generating Revenue
To view Teewinot Life Sciences’s complete valuation and funding history, request access »

Teewinot Life Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 0.000 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 0.000 00 00 00 00 00.000
To view Teewinot Life Sciences’s complete cap table history, request access »

Teewinot Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of patented biosynthetic manufacturing biotechnology methods designed to offer naturally-occurring cannabinoid
Drug Discovery
Tampa, FL
5 As of 2021
000.00
0000000000.

00000

iat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culp
0000 000000000
Seattle, WA
0 As of 0000
00000
000000000 00000

000000

olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut
0000 000000000
Rockville, MD
0 As of 0000
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Teewinot Life Sciences Competitors (51)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verda Bio Venture Capital-Backed Seattle, WA 0 00000 000000000 00000
CytImmune Sciences Private Equity-Backed Rockville, MD 0 000.00 000000000000 000.00
Orgenesis Corporation Germantown, MD 000 000.00 000000000-00 000.00
Nanna Therapeutics Formerly VC-backed Cambridge, United Kingdom 00 00000 000000&0 00000
Agios Pharmaceuticals Formerly VC-backed Cambridge, MA 000 00000 000000&0
You’re viewing 5 of 51 competitors. Get the full list »

Teewinot Life Sciences Patents

Teewinot Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3216970-A1 Synthesis of cbn and cbnv Pending 27-Apr-2021 0000000000
US-20240011058-A1 Cannabidiolic acid (cbda) synthase variants, and manufacture and use thereof Pending 13-Nov-2020 00000000
CA-3198488-A1 Cannabidiolic acid (cbda) synthase variants, and manufacture and use thereof Pending 13-Nov-2020 0000000000
CA-3198478-A1 Tetrahydrocannabinolic acid (thca) synthase variants, and manufacture and use thereof Pending 13-Nov-2020 0000000000000
US-20230407239-A1 Tetrahydrocannabinolic acid (thca) synthase variants, and manufacture and use thereof Pending 13-Nov-2020 C12N1/165
To view Teewinot Life Sciences’s complete patent history, request access »

Teewinot Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Teewinot Life Sciences FAQs

  • When was Teewinot Life Sciences founded?

    Teewinot Life Sciences was founded in 2009.

  • Who is the founder of Teewinot Life Sciences?

    Charles Brink JD, Leonard Sarna, Bryan Brink, Christopher Brink, and Richard Peet Ph.D are the founders of Teewinot Life Sciences.

  • Where is Teewinot Life Sciences headquartered?

    Teewinot Life Sciences is headquartered in Tampa, FL.

  • What is the size of Teewinot Life Sciences?

    Teewinot Life Sciences has 5 total employees.

  • What industry is Teewinot Life Sciences in?

    Teewinot Life Sciences’s primary industry is Drug Discovery.

  • Is Teewinot Life Sciences a private or public company?

    Teewinot Life Sciences is a Private company.

  • What is Teewinot Life Sciences’s current revenue?

    The current revenue for Teewinot Life Sciences is 000000.

  • How much funding has Teewinot Life Sciences raised over time?

    Teewinot Life Sciences has raised $19.3M.

  • Who are Teewinot Life Sciences’s competitors?

    Verda Bio, CytImmune Sciences, Orgenesis, Nanna Therapeutics, and Agios Pharmaceuticals are some of the 51 competitors of Teewinot Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »